United States Patent and Trademark Office
Home
|
Site Index
|
Search
|
Guides
|
Contacts
|
e
Business
|
eBiz alerts
|
News
|
Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0
Cancellation
Number:
92053139
Filing Date:
10/14/2010
Status:
Terminated
Status Date:
08/11/2011
General Contact Number:
571-272-8500
Interlocutory Attorney:
JENNIFER KRISP
Paralegal Name:
VICTORIA VISTAUXX VON
Defendant
Name:
Neuralieve, Inc.
Correspondence:
MARK A STEINER
DUANE MORRIS LLP
ONE MARKET PLZ, SPEAR TOWER STE 2200
SAN FRANCISCO, CA 94105
UNITED STATES
masteiner@duanemorris.com, lhvanlobensels@duanemorris.com, kxwhite@duanemorris.com, bcraney@duanemorris.com
Phone: 415-957-3000
Serial #:
76391203
Application File
Assignment
Registration #:
3015874
Application Status:
CANCELLED - SECTION 18
Mark:
NEURALIEVE
Plaintiff
Name:
Bayer HealthCare LLC
Correspondence:
BETH M GOLDMAN
ORRICK HERRINGTON & SUTCLIFFE LLP
405 HOWARD STREET
SAN FRANCISCO, CA 94105
UNITED STATES
beth.goldman@orrick.com
Phone: 415-773-5700
Serial #:
73726530
Application File
Assignment
Registration #:
1536042
Application Status:
REGISTERED AND RENEWED
Mark:
ALEVE
Serial #:
77105868
Application File
Assignment
Registration #:
3287780
Application Status:
REGISTERED AND RENEWED
Mark:
ALEVE
Prosecution History
#
Date
History Text
Due Date
15
08/11/2011
TERMINATED
14
08/11/2011
COMMISSIONER'S ORDER CANCELLING THE REGISTRATION
13
07/26/2011
BOARD'S DECISION: GRANTED
12
07/21/2011
VOLUNTARY SURRENDER OF REGISTRATION
11
05/18/2011
ANSWER
10
03/15/2011
EXTENSION OF TIME GRANTED
9
03/15/2011
STIPULATION FOR AN EXTENSION OF TIME
8
01/21/2011
EXTENSION OF TIME GRANTED
7
01/21/2011
STIPULATION FOR AN EXTENSION OF TIME
6
01/21/2011
CHANGE OF CORRESPONDENCE ADDRESS
5
11/17/2010
EXTENSION OF TIME GRANTED
4
11/17/2010
STIPULATION FOR AN EXTENSION OF TIME
3
10/15/2010
PENDING, INSTITUTED
2
10/15/2010
NOTICE AND TRIAL DATES SENT; ANSWER DUE:
11/24/2010
1
10/14/2010
FILED AND FEE
Results as of 11/22/2024 08:37 AM
Search:
|
.
HOME
|
INDEX
|
SEARCH
|
e
BUSINESS
|
CONTACT US
|
PRIVACY POLICY